Investors Press Releases Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences January 07, 2021 Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™ December 22, 2020 Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19 December 15, 2020 Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc. October 20, 2020 Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial September 25, 2020 Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference September 15, 2020 Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx™ August 26, 2020 Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor June 29, 2020 David Elsley Files Early Warning Report for Cardiol Therapeutics June 25, 2020 Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option June 04, 2020 Page 1 of 612345...»Last »
